Company Overview and News

 
U.S. business borrowing for equipment flat in April -ELFA

2018-05-23 reuters
(Reuters) - U.S. businesses borrowing to spend on capital goods was little changed in April from a year earlier, the Equipment Leasing and Finance Association (ELFA) said.

 
Stock Market News For May 23, 2018

2018-05-23 zacks
Markets ended lower on Tuesday erasing early gains, after President Donald Trump said that he wasn’t satisfied with the progress of United States-China trade talks. Moreover, Trump also said that the highly awaited summit between the United States and North Korea might not happen at all.

 
Why Caterpillar can't keep up with a boom in demand - Channel NewsAsia

2018-05-23 channelnewsasia
EAST PEORIA, Ill.: Orders for the mining machines and construction bulldozers made at this sprawling Caterpillar Inc. factory in central Illinois have jumped, in general, three-fold over the past year.

 
5 Top-Ranked Stocks Gearing Up for an Earnings Beat

2018-05-23 zacks
What drives shares or pulls them down after a company comes up with quarterly earnings? It’s not exactly how well a company performed in the recently concluded quarter or exhibited strong growth; it is an earnings beat or a miss which drives the market post release.

 
3 Stocks to Play Trump's Trade Talks with China | InvestorPlace

2018-05-23 investorplace
Stocks slipped through the cash session on Tuesday, as a late bout of selling pressure spoiled the mood, with the weakness continuing into the overnight futures session early Wednesday morning. The Russell 2000 small-cap index broke its streak of four consecutive record closes.

 
The Zacks Analyst Blog Highlights: Boeing, Caterpillar, Diodes, Texas Instruments and CNOOC

2018-05-23 zacks
Chicago, IL – May 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Boeing (BA - Free Report) , Caterpillar Inc. (CAT - Free Report) , Diodes Inc. (DIOD - Free Report) , Texas Instruments Inc. (TXN - Free Report) and CNOOC Limited (CEO - Free Report) .

 
Why Caterpillar can't keep up with a boom in demand

2018-05-23 reuters
EAST PEORIA, Ill. (Reuters) - Orders for the mining machines and construction bulldozers made at this sprawling Caterpillar Inc. (CAT.N) factory in central Illinois have jumped, in general, three-fold over the past year.

 
Boeing, Home Depot Weigh on Dow Tuesday

2018-05-22 247wallst
May 22, 2018: Markets opened higher again Tuesday but it’s been a bumpy day ever since, especially for the blue chips. Trading has been mixed all day with the energy sector the day’s biggest loser while financials and utilities have performed best. The FOMC releases the tea leaves, uh, minutes, of its latest meeting tomorrow. A slightly weakening dollar and still-high 10-year yields pretty much offset each other.

 
Stock Market News For May 22, 2018

2018-05-22 zacks
Markets closed sharply higher on Monday as trade war tensions between the United States and China declined for the time being. This saw a rally in industrials stocks. Both the Dow and S&P 500 closed at their highest level since March. All the three indexes ended the day in positive territory.

 
Is Caterpillar (CAT) Stock Outpacing Its Industrial Products Peers This Year?

2018-05-22 zacks
Investors focused on the Industrial Products space have likely heard of Caterpillar (CAT - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Industrial Products peers, we might be able to answer that question.

 
US-China Work Out Trade Truce: 5 Top Winners

2018-05-22 zacks
The United States and China have agreed to “substantially” lessen trade deficit following two days of negotiations. China promised to “significantly” purchase U.S. goods and services that soothed investors’ nerves to a fair extent.

 
4 Blue-Chip Stocks Rallying on a U.S.-China Trade Deal | InvestorPlace

2018-05-22 investorplace
U.S. equities were on a roll on Monday that looks set to continue Tuesday, with the Dow Jones Industrial Average crossing the 25,000 threshold for the first time since March.

 
Yes, Deere

2018-05-22 seekingalpha
In the spirit of the royal wedding, the two words that make up this article's title are the key to a long-term successful marriage when spoken to a spouse as opposed to arguing over the color of drapes, a certain style of furniture, or to a request to do a certain chore like cutting the lawn or plowing a field. However, in this case, I'm talking about saying yes to buying the stock named Deere & Company (DE).

1
Industrials Set to Gain as Trade War Fears Ease: 5 Picks

2018-05-22 zacks
Industrials emerged as the leading gainer on May 21 as stocks hit their highest level in two months. The immediate trigger for gains was a significant decline in trade tensions between the United States and China. Comments from the U.S. Treasury Secretary helped to reassure investors that negotiations between the two countries are proceeding smoothly.

 
The Zacks Analyst Blog Highlights: Western Digital, Magna International, Nucor, Sony and Caterpillar

2018-05-22 zacks
Chicago, IL – May 22, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Western Digital Corporation (WDC - Free Report) , Magna International Inc. (MGA - Free Report) , Nucor Corporation (NUE - Free Report) , Sony Corporation (SNE - Free Report) and Caterpillar Inc.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

16h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

17h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 149123101